Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference
January 05 2021 - 9:00AM
PR Newswire (US)
CARLSBAD, Calif., Jan. 5, 2021 /PRNewswire/ -- Qualigen
Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company
focused on developing novel therapeutics for the treatment of
cancer and infectious diseases, today announced that Michael Poirier, Chairman, Chief Executive
Officer and President, will present at the H.C. Wainwright
BioConnect 2021 Virtual Conference to be held January 11-14, 2021.
A webcast of the presentation will be accessible on demand
beginning Monday, January 11, 2021 on
the Qualigen Therapeutics website, https://www.qualigeninc.com/, in
the Investors section.
View original
content:http://www.prnewswire.com/news-releases/qualigen-therapeutics-to-present-at-the-hc-wainwright-bioconnect-2021-conference-301200916.html
SOURCE Qualigen, Inc.
Copyright 2021 PR Newswire
Qualigen Therapeutics (NASDAQ:QLGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Qualigen Therapeutics (NASDAQ:QLGN)
Historical Stock Chart
From Sep 2023 to Sep 2024